Celularity (CELU) Accumulated Expenses (2020 - 2025)
Celularity (CELU) posted quarterly Accumulated Expenses of $873000.0 for Q4 2025, down 95.74% year-over-year from $20.5 million in Q4 2024, and down 97.03% quarter-over-quarter from $29.4 million in Q3 2025.
Celularity (CELU) Accumulated Expenses (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Accumulated Expenses for 6 consecutive years, with $873000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Expenses fell 95.74% year-over-year to $873000.0; the TTM figure through Dec 2025 stood at $873000.0 (down 95.74% YoY), while the FY2025 annual figure was $873000.0, down 95.74% from the prior year.
- Accumulated Expenses fell to $873000.0 in Q4 2025 per CELU's latest filing, from $29.4 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $33.4 million in Q2 2025 and bottomed at $873000.0 in Q4 2025.
- Historically, Accumulated Expenses has averaged $15.0 million across 5 years, with a median of $12.5 million in 2021.
- On a YoY basis, Accumulated Expenses climbed as much as 221.35% in 2025 and fell as far as 95.74% in 2025.
- Celularity's Accumulated Expenses stood at $11.7 million in 2021, then dropped by 22.23% to $9.1 million in 2022, then decreased by 16.42% to $7.6 million in 2023, then surged by 170.34% to $20.5 million in 2024, then tumbled by 95.74% to $873000.0 in 2025.
- Business Quant data shows CELU's Accumulated Expenses at $873000.0 in Q4 2025, $29.4 million in Q3 2025, and $33.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 29.42 Mn |
| Jun 30, 2025 | 33.37 Mn |
| Mar 31, 2025 | 25.25 Mn |
| Dec 31, 2024 | 20.49 Mn |
| Sep 30, 2024 | 14.47 Mn |
| Jun 30, 2024 | 10.38 Mn |
| Mar 31, 2024 | 8.76 Mn |
| Dec 31, 2023 | 7.58 Mn |
| Sep 30, 2023 | 10.24 Mn |
| Jun 30, 2023 | 9.40 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Dec 31, 2022 | 9.07 Mn |
| Sep 30, 2022 | 18.51 Mn |
| Jun 30, 2022 | 20.48 Mn |
| Mar 31, 2022 | 13.44 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 17.10 Mn |
| Dec 31, 2020 | 13.45 Mn |